• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jenburkt Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4394.0
  • ISIN : INE354A01013
1,133.90 -12 (-1.03%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    1,127.30

  • Today’s High

    1,164.80

  • Open

    1,156.60

  • Perv Close

    1,145.75

  • 52W Low

    735.20

  • 52W High

    1,375.00

Key Indicators

  • P/E(TTM)

    15.61

  • Mar.Cap (₹Cr.)

    500.42

  • Div & Yield %

    1.59

  • Book Value(₹)

    389.22

  • Debt-Equity Ratio

    -1.03

  • AGM Date

    30-May-2025

  • EPS

    72.65

  • P/E Ratio

    15.61

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    500.42

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.41

  • BV (₹)

    389.20

  • Sales( ₹ in Cr.)

    151.69

  • NP (in Cr.)

    32.06

  • NP Var(%)

    24.0

  • Div%

    180.0

  • CPS (₹)

    78.80

  • EPS (₹)

    72.60

  • Traded Value (₹ in Lakhs)

    500.42

  • 52 Week High

    1,375.00

  • 52 Week Low

    735.20

  • Price BSE

    1134.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    500.42

  • P/C Ratio

    14.40

  • P/E Ratio

    15.60

  • Price Vs.BV

    72.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 141.97 136.75 123.98 109.29 118.89 122.64
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 141.97 136.75 123.98 109.29 118.89 122.64
Other Income 4.67 5.12 4.95 4.31 4.22 3.41
Stock Adjustments 0.39 -1.34 2.28 -3.18 0.49 2.49
Total Income 147.03 140.53 131.21 110.42 123.60 128.54
EXPENDITURE :            
Raw Materials 30.80 31.67 33.72 26.91 33.55 38.75
Power and Fuel Cost 0.75 0.76 0.61 0.50 0.59 0.59
Employee Cost 42.49 38.81 36.49 32.38 36.51 31.20
Other Manufacturing Expenses 3.58 4.28 3.85 2.50 2.98 1.23
Selling and Administration Expenses 31.04 29.03 24.32 23.03 25.46 28.10
Miscellaneous Expenses 0.58 0.50 0.01 0.95 0.54 0.30
Employee Benefit Expenses 42.49 38.81 36.49 32.38 36.51 31.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 109.24 105.05 99.01 86.26 99.63 100.18
Operating Profit 37.79 35.49 32.20 24.15 23.97 28.38
Interest 0.27 0.37 0.43 0.47 0.53 0.39
Gross Profit 37.52 35.12 31.77 23.68 23.44 27.99
Depreciation 2.34 2.26 1.90 2.04 2.30 1.35
Profit Before Tax 35.18 32.86 29.87 21.64 21.14 26.64
Current Tax 9.72 8.48 7.28 5.53 5.90 7.14
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.52 -0.23 0.30 -0.39 0.37 -0.31
Reported Net Profit 25.98 24.61 22.30 16.50 14.87 19.80
Extraordinary Items 0.04 0.00 0.14 0.00 0.00 -0.02
Adjusted Net Profit 25.94 24.61 22.16 16.50 14.87 19.82
Adjustment below Net Profit 0.00 -14.34 0.00 0.00 -1.60 -0.57
P & L Balance brought forward 113.11 108.53 90.91 74.41 69.42 53.27
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.96 5.69 4.68 0.00 8.28 3.09
P & L Balance carried down 134.12 113.10 108.53 90.91 74.41 69.42
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 153.00 144.00 120.00 102.00 81.00 102.00
Dividend Per Share(Rs) 15.30 14.40 12.00 10.20 8.10 10.20
Earnings Per Share-Unit Curr 58.86 55.76 48.58 35.96 32.40 43.14
Earnings Per Share(Adj)-Unit Curr 58.86 55.76 48.58 35.96 32.40 43.14
Book Value 328.42 277.32 255.77 214.55 174.32 168.79
Book Value(Adj)-Unit Curr 328.42 277.32 255.77 214.55 174.32 168.79

Shareholding Pattern

  • Promoter Group

    46.68%

  • Public Share Holding

    53.32%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 616,128 13.96 616,128 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,443,962 32.72 1,443,962 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,060,090 46.68 2,060,090 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,190 0.12 5,190 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,190 0.12 5,190 1
2] Non Institution
Bodies Corporate 134,394 3.05 133,794 48
Clearing Members 5,301 0.12 5,301 6
Directors of their Relatives 900 0.02 900 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 136,090 3.08 136,090 171
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 53,840 1.22 53,840 181
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 518,910 11.76 518,910 10
Individuals holding nominal share capital up to Rs. 1 lakh 1,403,003 31.79 1,300,703 6,556
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 95,582 2.17 95,582 2
Sub Total 2,348,020 53.20 2,245,120 6,976
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,413,300 100.00 4,310,400 6,987

Company Background

Jenburkt Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Jenburkt Pharmaceuticals Ltd
  • BSE Code : 4394.0
  • ISIN : INE354A01013

  • Incorporation Year

    1985

  • Registered Office

    Nirmala Apartment P B No 37396
    93 Jayprakash Road Andheri(W), Mumbai,
    Maharashtra-400058

  • Telephone

    91-22-66943121/67603603

  • FAX

    91-22-66943127

  • Chairman

    Ashish U Bhuta

  • Managing Director

    Ashish U Bhuta

  • Company Secretary

    Ashish R Shah

  • Auditor

    D R Mehta & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Jenburkt Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jenburkt Pharma 1,133.90 146.63 141.97 15.61 25.67
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92